Etyyliglukuronidin Esiintyminen Virtsassa äitiysneuvola- ja äitiyspoliklinikkakäyntien yhteydessä HUS:n ja PHHYKY:n Alueella
Sponsor study identifier
observational
505
1 country
4
Study Start
October 1, 2020
Actual (reported)Primary Completion
July 30, 2021
Actual (reported)Study Completion
July 30, 2021
Actual (reported)In order to find how many women continue using alcohol during their pregnancies the plan is to anonymously test routine urine samples collected during pregnancies for ethylglucuronide (ETG), a metabolite of ethanol that is detectable in urine up to several days after alcohol consumptions. Altogether 600 samples are taken in the prenatal care units and the prenatal care units dedicated for the alcohol and drug abusing mothers both in the Helsinki and Lahti areas. Test results are used to estimate and compare the prevalence of severe maternal drinking in the different populations.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
July 30, 2021
Actual (reported)Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
September 25, 2020
Actual (reported)October 1, 2020
Actual (reported)October 1, 2020
Actual (reported)July 30, 2021
Actual (reported)July 30, 2021
Actual (reported)EtG
The routine urine samples from the visitors are tested for ethyl glucuronide using dip sticks with 300ng cut off. Positve finds are confirmed in a laboratory.
Day 1
Nicotine
Day 1
Cannabis
Day 1
Mothers visiting the prenatal care units within the Helsinki area.
Mothers visiting the prenatal care units dedicated for the alcohol and drug abusing mothers within the Helsinki area.
Mothers visiting the prenatal care units within the Lahti area.
Mothers visiting the prenatal care units dedicated for the alcohol and drug abusing mothers within the Lahti area.
The study population for the ethylglucuronide (EtG) testing consists of the visitors in the HYKS, PHHYKY and the cities of Helsinki and Lahti prenatal care units, as well as the HYKS and PHHKYKY prenatal care units dedicated for the alcohol and drug abusing mothers (HAL- / HALSO-poliklinikka).
Contact the study team to confirm eligibility.
HALSO-poliklinikka
Lahti, Paijat-Hame Region, 715850, Finland
Äitiyspoliklinikka/neuvola
Lahti, Paijat-Hame Region, 715850, Finland
HAL-poliklinikka
Helsinki, Uusimaa, 00029, Finland
Äitiyspoliklinikka/neuvola
Helsinki, Uusimaa, 00120, Finland
Jolma M, Koivu-Jolma M, Niemela O, Autti-Ramo I, Kahila H. Rapid urine screening for ethyl glucuronide from pregnant women as a tool for detecting prenatal alcohol exposure. BMC Pregnancy Childbirth. 2023 Jun 22;23(1):464. doi: 10.1186/s12884-023-05789-x.
urine
Hanna Kahila, MD
HUCS
505 participants (actual enrollment reported by the registry).
First Submitted
September 25, 2020
First Posted
October 1, 2020
Study Start
October 1, 2020
Actual (reported)Fetal Alcohol Spectrum Disorder-Is This a Ciliopathy?
Primary Completion
July 30, 2021
Actual (reported)Study Completion
July 30, 2021
Actual (reported)Last Updated
November 28, 2022
Record last verified: 2022-11
All collected anonymized IPD and the modeling source code will be shared.
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: